Viking Therapeutics (VKTX) released new clinical trial data on Sunday for its experimental weight-loss drugs, which include a highly anticipated oral pill. The San Diego-based company’s stock ...

Canada's health regulator has approved Novo Nordisk's weight-loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

E xcitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs Ozempic and Wegovy. Novo Nordisk, the manufacturer of both, recently ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite ... suppressing appetite and stimulating weight loss. Nausea is a commonly reported side effect.

Wednesday, November 30, 2022 ... the highest dose of the drug lost 21 percent of their total body weight, according to a randomized-controlled trial published in the New England Journal of ...

The drug, called amycretin, helped volunteer patients lose a whopping 13 percent of their body weight over just 12 weeks. That means the new pill may be even more effective than the company's ...

The new anti-obesity ... in terms of weight loss (up to -8.3% from baseline) were also observed on the 57th day of follow-up, 4 weeks after the administration of the last pill.

Nov 20 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab has launched its wildly popular weight-loss drug Wegovy in more ... but it took Novo until December 2022 to make all doses available ...